CD274 and non-small cell lung carcinoma: A standardized method of detecting PD-L1expression maybe provide support for patients who are initially diagnosed with primary NSCLC by allowing for early anti-PD-1 or anti-PD-L1 monoclonal antibody immunotherapy, thus improving treatment efficacy and managing cost.